Eballena, Zaye Seff .
HRN: 23-47-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/07/2024
09/13/2024
IVTT
140mg
Q24h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes